Udaka S - Search Results

1

Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies.

Byun Y, Ohmura M, Fujihashi K, Yamamoto S, McGhee JR, Udaka S, Kiyono H, Takeda Y, Kohsaka T, Yuki Y. Byun Y, et al. Among authors: udaka s. Vaccine. 2001 Feb 28;19(15-16):2061-70. doi: 10.1016/s0264-410x(00)00411-4. Vaccine. 2001. PMID: 11228378

2

Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.

Yuki Y, Byun Y, Fujita M, Izutani W, Suzuki T, Udaka S, Fujihashi K, McGhee JR, Kiyono H. Yuki Y, et al. Among authors: udaka s. Biotechnol Bioeng. 2001 Jul 5;74(1):62-9. doi: 10.1002/bit.1095. Biotechnol Bioeng. 2001. PMID: 11353411

3

Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.

Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S. Yuki Y, et al. Among authors: udaka s. Biotechnol Bioeng. 2005 Dec 30;92(7):803-9. doi: 10.1002/bit.20654. Biotechnol Bioeng. 2005. PMID: 16142801

4

Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity.

Kozuka S, Yasuda Y, Isaka M, Masaki N, Taniguchi T, Matano K, Moriyama A, Ohkuma K, Goto N, Udaka S, Tochikubo K. Kozuka S, et al. Among authors: udaka s. Vaccine. 2000 Mar 6;18(17):1730-7. doi: 10.1016/s0264-410x(99)00547-2. Vaccine. 2000. PMID: 10699320

5

Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis.

Ichikawa Y, Yamagata H, Tochikubo K, Udaka S. Ichikawa Y, et al. Among authors: udaka s. FEMS Microbiol Lett. 1993 Aug 1;111(2-3):219-24. doi: 10.1111/j.1574-6968.1993.tb06389.x. FEMS Microbiol Lett. 1993. PMID: 8405930

6

Extracellular production of riboflavin-binding protein, a potential bitter inhibitor, by Brevibacillus choshinensis.

Maehashi K, Matano M, Saito M, Udaka S. Maehashi K, et al. Among authors: udaka s. Protein Expr Purif. 2010 May;71(1):85-90. doi: 10.1016/j.pep.2009.12.016. Epub 2010 Jan 4. Protein Expr Purif. 2010. PMID: 20045733

7

Efficient production of human alpha-amylase by a Bacillus brevis mutant.

Konishi H, Sato T, Yamagata H, Udaka S. Konishi H, et al. Among authors: udaka s. Appl Microbiol Biotechnol. 1990 Dec;34(3):297-302. doi: 10.1007/BF00170046. Appl Microbiol Biotechnol. 1990. PMID: 1367195

8

Secretion of human interleukin-2 in biologically active form by Bacillus brevis directly into culture medium.

Takimura Y, Kato M, Ohta T, Yamagata H, Udaka S. Takimura Y, et al. Among authors: udaka s. Biosci Biotechnol Biochem. 1997 Nov;61(11):1858-61. doi: 10.1271/bbb.61.1858. Biosci Biotechnol Biochem. 1997. PMID: 9404065 Free article.

9

Efficient production of casoxin D, a bradykinin agonist peptide derived from human casein, by Bacillus brevis.

Kato M, Fujiwara Y, Okamoto A, Yoshikawa M, Chiba H, Udaka S. Kato M, et al. Among authors: udaka s. Biosci Biotechnol Biochem. 1995 Nov;59(11):2056-9. doi: 10.1271/bbb.59.2056. Biosci Biotechnol Biochem. 1995. PMID: 8541641 Free article.

10

Secretory production of erythropoietin and the extracellular domain of the erythropoietin receptor by Bacillus brevis: affinity purification and characterization.

Nagao M, Inoue K, Moon SK, Masuda S, Takagi H, Udaka S, Sasaki R. Nagao M, et al. Among authors: udaka s. Biosci Biotechnol Biochem. 1997 Apr;61(4):670-4. doi: 10.1271/bbb.61.670. Biosci Biotechnol Biochem. 1997. PMID: 9145527 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters